Improved Vision-Related Function after Ranibizumab for Macular Edema after Retinal Vein Occlusion

Klein, 2000, The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study, Trans Am Ophthalmol Soc, 98, 133 Rehak, 2008, Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities, Curr Eye Res, 33, 111, 10.1080/02713680701851902 Mitchell, 1996, Prevalence and associations of retinal vein occlusion in Australia: the Blue Mountains Eye Study, Arch Ophthalmol, 114, 1243, 10.1001/archopht.1996.01100140443012 Rehak, 2010, Retinal vein thrombosis: pathogenesis and management, J Thromb Haemost, 8, 1886, 10.1111/j.1538-7836.2010.03909.x 1984, Argon laser photocoagulation for macular edema in branch vein occlusion, Am J Ophthalmol, 98, 271, 10.1016/0002-9394(84)90316-7 Prisco, 2002, Retinal vein thrombosis: risk factors, pathogenesis and therapeutic approach, Pathophysiol Haemost Thromb, 32, 308, 10.1159/000073587 Campochiaro, 2012, Anti-vascular endothelial growth factor treatment for retinal vein occlusions, Ophthalmologica, 227, 30, 10.1159/000337157 London, 2011, Update and review of central retinal vein occlusion, Curr Opin Ophthalmol, 22, 159, 10.1097/ICU.0b013e3283459737 Campochiaro, 2010, Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study, Ophthalmology, 117, 1102, 10.1016/j.ophtha.2010.02.021 Brown, 2010, Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study, Ophthalmology, 117, 1124, 10.1016/j.ophtha.2010.02.022 Campochiaro, 2011, Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study, Ophthalmology, 118, 2041, 10.1016/j.ophtha.2011.02.038 Brown, 2011, Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study, Ophthalmology, 118, 1594, 10.1016/j.ophtha.2011.02.022 Mangione, 2001, Development of the 25-item National Eye Institute Visual Function Questionnaire, Arch Ophthalmol, 119, 1050, 10.1001/archopht.119.7.1050 Mangione, 1998, Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ), Arch Ophthalmol, 116, 1496, 10.1001/archopht.116.11.1496 Mangione, 2000 Cahill, 2005, Quality of life after macular translocation with 360 degrees peripheral retinectomy for age-related macular degeneration, Ophthalmology, 112, 144, 10.1016/j.ophtha.2004.06.035 Miskala, 2004, Relative contributions of reduced vision and general health to NEI-VFQ scores in patients with neovascular age-related macular degeneration, Arch Ophthalmol, 122, 758, 10.1001/archopht.122.5.758 2003, Responsiveness of the National Eye Institute Visual Function Questionnaire to changes in visual acuity: findings in patients with subfoveal choroidal neovascularization—SST report no. 1, Arch Ophthalmol, 121, 531, 10.1001/archopht.121.4.531 2005, Responsiveness of the National Eye Institute Visual Function Questionnaire to progression to advanced age-related macular degeneration, vision loss, and lens opacity: AREDS report no. 14, Arch Ophthalmol, 123, 1207, 10.1001/archopht.123.9.1207 2007, Evaluation of minimum clinically meaningful changes in scores on the National Eye Institute Visual Function Questionnaire (NEI-VFQ) SST report number 19, Ophthalmic Epidemiol, 14, 205, 10.1080/09286580701502970 Azen, 2002, Binocular visual acuity summation and inhibition in an ocular epidemiological study: the Los Angeles Latino Eye Study, Invest Ophthalmol Vis Sci, 43, 1742 Bressler, 2010, Vision-related function after ranibizumab treatment by better- or worse-seeing eye: clinical trial results from MARINA and ANCHOR, Ophthalmology, 117, 747, 10.1016/j.ophtha.2009.09.002 Berdeaux, 2005, Vision-related quality of life in patients suffering from age-related macular degeneration, Am J Ophthalmol, 139, 271, 10.1016/j.ajo.2004.09.028 Damiano, 1995, Comparison of generic versus disease-specific measures of functional impairment in patients with cataract, Med Care, 33, AS120 Datta, 2008, The importance of acuity, stereopsis, and contrast sensitivity for health-related quality of life in elderly women with cataracts, Invest Ophthalmol Vis Sci, 49, 1, 10.1167/iovs.06-1073 Desai, 1996, Gains from cataract surgery: visual function and quality of life, Br J Ophthalmol, 80, 868, 10.1136/bjo.80.10.868 Elliott, 2000, Improvements in clinical and functional vision and quality of life after second eye cataract surgery, Optom Vis Sci, 77, 13, 10.1097/00006324-200001000-00009 Gothwal, 2011, Improvements in visual ability with first-eye, second-eye, and bilateral cataract surgery measured with the visual symptoms and quality of life questionnaire, J Cataract Refract Surg, 37, 1208, 10.1016/j.jcrs.2011.01.028 Harwood, 2005, Falls and health status in elderly women following first eye cataract surgery: a randomised controlled trial, Br J Ophthalmol, 89, 53, 10.1136/bjo.2004.049478 Steinberg, 1994, National study of cataract surgery outcomes: variation in 4-month postoperative outcomes as reflected in multiple outcome measures, Ophthalmology, 101, 1131, 10.1016/S0161-6420(94)31210-3